Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alessandro Doria, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Alessandro Doria and Mario Luca Morieri.
Connection Strength

3.199
  1. Insufficient Evidence for Interaction Between Haptoglobin Phenotypes and Intensive Glycemic Control on Cardiovascular Outcomes. J Am Coll Cardiol. 2020 06 16; 75(23):2995-2996.
    View in: PubMed
    Score: 0.911
  2. PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid. Diabetes. 2020 04; 69(4):771-783.
    View in: PubMed
    Score: 0.887
  3. Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial. Diabetes Care. 2018 Nov; 41(11):2404-2413.
    View in: PubMed
    Score: 0.809
  4. Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD. Diabetes Care. 2018 02; 41(2):348-355.
    View in: PubMed
    Score: 0.191
  5. Variants in ANGPTL4 and the Risk of Coronary Artery Disease. N Engl J Med. 2016 12 08; 375(23):2304-2305.
    View in: PubMed
    Score: 0.179
  6. Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial. Diabetes Care. 2016 Nov; 39(11):1915-1924.
    View in: PubMed
    Score: 0.175
  7. Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes. Clin Pharmacol Ther. 2018 04; 103(4):712-721.
    View in: PubMed
    Score: 0.048
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.